• 1
    American Cancer Society. Cancer Prevention and Early Detection, Facts andFigures 2007. Atlanta, Ga: American Cancer Society; 2007.
  • 2
    Ries LAG,Eisner MP,Kosary CL, et al. SEER Cancer Statistics Review, 1975–2002. Bethesda, Md: National Cancer Institute; 2004. Available at:, based on November 2004 SEER data submission, posted to the SEER website 2005. Accessed May 19, 2008.
  • 3
    Lund MJ,Brawley OP,Ward KC,Young JL,Gabram SS,Eley WJ. Parity and disparity in first course treatment of invasive breast cancer. Breast Cancer Res Treat. 2007 Jul 21 [Epub ahead of print].
  • 4
    Li CI,Malone KE,Daling JR. Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med. 2003; 163: 4956.
  • 5
    Chu KC,Lamar CA,Freeman HP. Racial disparities in breast carcinoma survival rates: separating factors that affect diagnosis from factors that affect treatment. Cancer. 2003; 97: 28532860.
  • 6
    Dignam JJ. Differences in breast cancer prognosis among African-American and Caucasian women. CA Cancer J Clin. 2000; 50: 5064.
  • 7
    McWhorter WP,Mayer WJ. Black/white differences in type of initial breast cancer treatment and implications for survival. Am J Public Health. 1987; 77: 15151517.
  • 8
    Newman LA,Theriault R,Clendinnin N, et al. Treatment choices and response rates in African-American women with breast carcinoma. Cancer. 2003; 97( 1 suppl): 246252.
  • 9
    Caplan LS,Helzlsouer KJ,Shapiro S, et al. System delay in breast cancer in whites and blacks. Am J Epidemiol. 1995; 142: 804812.
  • 10
    Caplan LS,Helzlsouer KJ,Shapiro S,Wesley MN,Edwards BK. Reasons for delay in breast cancer diagnosis. Prev Med. 1996; 25: 218224.
  • 11
    Dennis CR,Gardner B,Lim B. Analysis of survival and recurrence versus patient and doctor delay in treatment of breast cancer. Cancer. 1975; 35: 714720.
  • 12
    Gwyn K,Bondy ML,Cohen DS, et al. Racial differences in diagnosis, treatment, and clinical delays in a population-based study of patients with newly diagnosed breast carcinoma. Cancer. 2004; 100: 15951604.
  • 13
    Richards MA,Westcombe AM,Love SB, et al. Influence of delay on survival in patients with breast cancer: a systematic review [see comment]. Lancet. 1999; 353: 11191126.
  • 14
    Gregorio DI,Cummings KM,Michalek A. Delay, stage of disease, and survival among white and black women with breast cancer. Am J Public Health. 1983; 73: 590593.
  • 15
    Lannin DR,Mathews HF,Mitchell J, et al. Influence of socioeconomic and cultural factors on racial differences in late-stage presentation of breast cancer. JAMA. 1998; 279: 18011807.
  • 16
    Gates MF,Lackey NR,Brown G. Caring demands and delay in seeking care in African-American women newly diagnosed with breast cancer: an ethnographic, photographic study. Oncol Nurs Forum. 2001; 28: 529537.
  • 17
    Li CI,Malone KE,Daling JR. Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older. Cancer Epidemiol Biomarkers Prev. 2002; 11: 601607.
  • 18
    Bach PB,Schrag D,Brawley OW, et al. Survival of blacks and whites after a cancer diagnosis. JAMA. 2002; 287: 21062113.
  • 19
    Hunter CP,Redmond CK,Chen VW, et al. Breast cancer: factors associated with stage at diagnosis in black and white women. Black/White Cancer Survival Study Group. J Natl Cancer Inst. 1993; 85: 11291137.
  • 20
    Eley JW,Hill HA,Chen VW, et al. Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study. JAMA. 1994; 272: 947954.
  • 21
    West DW,Satariano WA,Ragland DR, et al. Comorbidity and breast cancer survival: a comparison between black and white women. Ann Epidemiol. 1996; 6: 413419.
  • 22
    Yood MU,Johnson CC,Blount A, et al. Race and differences in breast cancer survival in a managed care population. J Natl Cancer Inst. 1999; 91: 14871491.
  • 23
    Jatoi I,Becher H,Leake CR. Widening disparity in survival between white and African-American patients with breast carcinoma treated in the U.S. Department of Defense Healthcare system. Cancer. 2003; 98: 894899.
  • 24
    Roetzheim RG,Gonzalez EC,Ferrante JM, et al. Effects of health insurance and race on breast carcinoma treatments and outcomes. Cancer. 2000; 89: 22022213.
  • 25
    Brawley OW. Disaggregating the effects of race and poverty on breast cancer outcomes [comment]. J Natl Cancer Inst. 2002; 94: 471473.
  • 26
    Wojcik BE,Spinks MK,Optenberg SA. Breast carcinoma survival analysis for African-American and white women in an equal-access health care system. Cancer. 1998; 82: 13101318.
  • 27
    Chlebowski RT,Chen Z,Anderson GL, et al. Ethnicity and breast cancer: factors influencing differences in incidence and outcome. J Natl Cancer Inst. 2005; 97: 439448.
  • 28
    Newman LA,Mason J,Cote D, et al. African-American ethnicity, socioeconomic status, and breast cancer survival: a meta-analysis of 14 studies involving over 10,000 African-American and 40,000 white American patients with carcinoma of the breast. Cancer. 2002; 94: 28442854.
  • 29
    Newman LA,Griffith KA,Jatoi I, et al. Meta-analysis of survival in African-American and white American patients with breast cancer: ethnicity compared with socioeconomic status. J Clin Oncol. 2006; 24: 13421349.
  • 30
    Howard J,Hankey BF,Greenberg RS, et al. A collaborative study of differences in the survival rates of black patients and white patients with cancer. Cancer. 1992; 69: 23492360.
  • 31
    Smith-Bindman R,Miglioretti DL,Lurie N, et al. Does utilization of screening mammography explain racial and ethnic differences in breast cancer? Ann Intern Med. 2006; 144: 541553.
  • 32
    Chu KC,Anderson WF. Rates for breast cancer characteristics by estrogen and progesterone receptor status in the major racial/ethnic groups. Breast Cancer Res Treat. 2002; 74: 199211.
  • 33
    Chu KC,Anderson WF,Fritz A, et al. Frequency distributions of breast cancer characteristics classified by estrogen receptor and progesterone receptor status for 8 racial/ethnic groups. Cancer. 2001; 92: 3745.
  • 34
    Carey L,Perou C,Livasy C, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006; 295: 24922502.
  • 35
    Jones BA,Kasl SV,Howe CL, et al. African-American/white differences in breast carcinoma: p53 alterations and other tumor characteristics [see comment]. Cancer. 2004; 101: 12931301.
  • 36
    Porter PL,Lund MJ,Lin MG, et al. Racial differences in expression of cell cycle regulatory proteins in breast cancer: study of young African-American and white women in Atlanta. Cancer. 2004; 100: 25332542.
  • 37
    Lund MJ,Eley JW,Liff JM, et al. Racial differences in triple negative breast tumors among women in Atlanta [oral presentation]. Presented at the 97th Annual Meeting of the American Association for Cancer Research, Washington, DC, April 2, 2006. Abstract LB-4.
  • 38
    Holmberg L,Ponten J,Adami HO. The biology and natural history of breast cancer from the screening perspective. World J Surg. 1989; 13: 2530.
  • 39
    Gilliland FD,Joste N,Stauber PM, et al. Biologic characteristics of interval and screen-detected breast cancers [comment]. J Natl Cancer Inst. 2000; 92: 743749.
  • 40
    Royak-Schaler R,Rose DP. Mammography screening and breast cancer biology in African-American women—a review. Cancer Detect Prev. 2002; 26: 180191.
  • 41
    Buist DS,Porter PL,Lehman C, et al. Factors contributing to mammography failure in women aged 40–49 years. J Natl Cancer Inst. 2004; 96: 14321440.
  • 42
    Mandelson MT,Oestreicher N,Porter PL, et al. Breast density as a predictor of mammographic detection: comparison of interval-and screen-detected cancers. J Natl Cancer Inst. 2000; 92: 10811087.
  • 43
    Collett K,Stefansson IM,Eide J, et al. A basal epithelial phenotype is more frequent in interval breast cancers compared with screen detected tumors. Cancer Epidemiol Biomarkers Prev. 2005; 14: 11081112.
  • 44
    Saslow D,Boetes C,Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007; 57: 7589.
  • 45
    Griggs JJ,Sorbero ME,Stark AT, et al. Racial disparity in the dose and dose intensity of breast cancer adjuvant chemotherapy. Breast Cancer Res Treat. 2003; 81: 2131.
  • 46
    Finn RS,Dering J,Ginther C, et al. Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/“triple-negative” breast cancer cell lines growing in vitro. Breast Cancer Res Treat. 2007; 105: 319326.
  • 47
    Freeman HP,Chu KC. Determinants of cancer disparities: barriers to cancer screening, diagnosis, and treatment. Surg Oncol Clin North Am. 2005; 14: 655669.
  • 48
    Dohan D,Schrag D. Using navigators to improve care of underserved patients. Cancer. 2005; 104: 848855.
  • 49
    Rizzo M,Reisman N,Gabram S, et al. Differences in treatment in stage III breast cancer in African-American women [abstract]. J Clin Oncol. 2007; 25(pt I): 18S. Abstract 504.
  • 50
    Lund MJB,Gabram SGA,Hatchett N, et al. High prevalence of triple negative breast cancers among black women in an urban cancer center [abstract]. Presented at the 29th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, December 14–17, 2006. Breast Cancer Res Treat. 2006;100(suppl 1):S141. Abstract 3052.